Funding For New Rapid Blood Test To Help Detect Heart Attacks: Atomo Partners with Anteo

Anteo is pleased to announce that it will partner with Sydney-based Atomo Diagnostics to develop a clinical prototype of a cost effective and accurate point of care test for the

Continue
Video: Mix&Go™ Could Solve Clinical Sample Interference

The lecture our VP of Scientific Affairs, Josh Soldo gave at AACC 2015 is now available. Lecture summary Interference is a substance present in a patient specimen that can alter

Continue
Anteo Diagnostics 2015 Annual Report Available Now

The Anteo Diagnostics 2015 Annual Report is now available and includes: Chairman’s Report CEO’s Report Operating and Financial Review Report Statutory Reports DOWNLOAD THE ANTEO DIAGNOSTICS 2015 ANNUAL REPORT HERE

Continue
Anteo Diagnostics to Acquire Established Global Diagnostics Company DIAsource ImmunoAssays SA

26 August 2015 – The Board of Directors of Anteo Diagnostics (ASX: ADO) (Anteo) is pleased to announce that it will acquire DIAsource ImmunoAssays, SA (DIAsource), an established global specialty

Continue
CEO Activities Report – Quarter Ended 30 June 2015

The Company has been extremely busy in the period since our last report. This CEO Activities Report provides context and further information on the highlights of last quarter. In summary:

Continue